Citywire printed articles sponsored by:
View the article online at http://citywire.co.uk/new-model-adviser/article/a385074
on May 01, 2013 at 00:01
Citywire Selection Verdict: Adrian Frost and Adrian Gosden have a talent for selecting overseas companies and make full use of their maximum 20% global allocation which helps them to gain exposure to large international pharmaceuticals. The duo remain overweight in health care and keep faith with UK listed majors GlaxoSmithKline and Astrazeneca. The fund performs well in both good and bad markets and has delivered consistent returns with a healthy yield of around 5%. A good pick for the long and short term investor.
For more information view the latest fund factsheet .
News sponsored by:
Today's top headlines
Challenged by growing risk aversion?
Challenging financial markets over recent years have resulted in growing risk aversion among British savers and led many to seek safety in cash. Click here for more.
More about this article:
Look up the funds
Look up the shares
- BG Group PLC (BG.)
- BP PLC (BP.)
- Lloyds Banking Group PLC (LLOY)
- International Power PLC (IPR)
- HSBC Holdings PLC (HSBA)
- Ashmore Group PLC (ASHM.L)
- Man Group plc (EMG.L)
- Tate and Lyle PLC (TATE.L)
- BT Group PLC (BT.L)